Interestingly, combined treatment with β-asarone and L-dopa reduced the level of creatinine and increased the level of HVA, DA, DOPAC, and 5-HT, while β-asarone also enhanced TH and DAT protein expression in madopar-induced PD rats [321]. This evidence concerns the gene SLC6A3 and Parkinson disease.